DCM
AHCO icon

Dupont Capital Management’s AdaptHealth AHCO Stock Holding History

Dupont Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,288
Closed -$374K – 1699
2021
Q4 		$374K Buy
+15,288
New +$359K 0.01% 907

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dupont Capital Management's AHCO Position: Q1 2022 in Review

Dupont Capital Management sold out of AdaptHealth (AHCO) in Q1 2022, closing a stake of 15,288 shares — an estimated $374K sold.

Dupont Capital Management first reported a position in AHCO in Q4 2021 and held it in 1 quarter. The position peaked at $374K in Q4 2021. 154 funds tracked by Wall St. Rank hold AHCO as of Q1 2022.

  • Dupont Capital Management reported no remaining AdaptHealth position as of Q1 2022 after selling out during the quarter.
  • Dupont Capital Management sold 15,288 AdaptHealth shares in Q1 2022, an estimated $374K.
  • Dupont Capital Management first reported a position in AdaptHealth in Q4 2021 and held it in 1 quarter.
  • Dupont Capital Management's AdaptHealth position peaked at $374K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2022.

Based on Dupont Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.